People are taking these medications, and obviously theres a tremendous amount of upside, Horneff said
In January 2025, the FDA also approved Ozempic for use in reducing some of the risks connected with chronic kidney disease
Found, for example, promotes a whole-body approach - GLP-1 prescriptions plus behavioral coaching and progress tracking - while Sequence offers a fully digital clinical team integrated with WeightWatchers ecosystem
For ongoing coverage of these issues, visit Pharmaceutical Executive and Pharmaceutical Commerce to stay on top of the latest challenges and solutions in the GLP-1 space.
doi: 10.1186/s40364-024-00643-4
Microdoses, however, usually come from compounding pharmacies, which formulate custom doses